126 related articles for article (PubMed ID: 7755923)
1. Does the choice of Pneumocystis carinii prophylaxis influence the prevalence of Enterocytozoon bieneusi microsporidiosis in AIDS patients?
Albrecht H; Sobottka I; Stellbrink HJ; Greten H
AIDS; 1995 Mar; 9(3):302-3. PubMed ID: 7755923
[No Abstract] [Full Text] [Related]
2. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia.
Warnock AC; Rimland D
Pharmacotherapy; 1996; 16(6):1030-8. PubMed ID: 8947975
[TBL] [Abstract][Full Text] [Related]
3. Pneumocystis carinii pneumonia prophylaxis during pregnancy.
Connelly RT; Lourwood DL
Pharmacotherapy; 1994; 14(4):424-9. PubMed ID: 7937279
[TBL] [Abstract][Full Text] [Related]
4. Intravenous pentamidine as an alternate for Pneumocystis carinii pneumonia prophylaxis in children with HIV infection.
Gupta M; Stephenson K; Gauar S; Frenkel L
Pediatr Pulmonol Suppl; 1997; 16():199-200. PubMed ID: 9443273
[No Abstract] [Full Text] [Related]
5. Primary prophylaxis against opportunistic infections in patients with AIDS.
Clumeck N
N Engl J Med; 1995 Mar; 332(11):739-40. PubMed ID: 7854383
[No Abstract] [Full Text] [Related]
6. A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens.
Ioannidis JP; Cappelleri JC; Skolnik PR; Lau J; Sacks HS
Arch Intern Med; 1996 Jan; 156(2):177-88. PubMed ID: 8546551
[TBL] [Abstract][Full Text] [Related]
7. Polypharmacy: dangers of multiple-drug therapy in patients with immunodeficiency virus infection.
Ungvarski P; Schmidt J
Home Healthc Nurse; 1993; 11(2):68-9. PubMed ID: 8478201
[No Abstract] [Full Text] [Related]
8. Trimethoprim-sulfamethoxazole prophylaxis of Pneumocystis carinii pneumonia in infants.
Mueller BU; Pizzo PA
Pediatr Infect Dis J; 1992 Dec; 11(12):1072-3. PubMed ID: 1461709
[No Abstract] [Full Text] [Related]
9. [Therapy and prevention of pneumocystis carinii pneumonia].
Goebel FD; Bogner JR
Internist (Berl); 1995 Dec; 36(12):1150-5. PubMed ID: 8567220
[No Abstract] [Full Text] [Related]
10. Impact of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in a cohort of 1000 patients with AIDS.
Monforte AD; Mainini F; Bini T; Moscatelli GC; Antinori S; Formenti T; Testa L; Mena M; Moroni M
J Chemother; 1995 Nov; 7 Suppl 4():184-6. PubMed ID: 8904150
[No Abstract] [Full Text] [Related]
11. Prevention and treatment of pneumocystis pneumonia.
Masur H
N Engl J Med; 1992 Dec; 327(26):1853-60. PubMed ID: 1448123
[No Abstract] [Full Text] [Related]
12. Bactrim approved for prophylaxis.
AIDS Patient Care; 1994 Jun; 8(3):166. PubMed ID: 11362143
[No Abstract] [Full Text] [Related]
13. Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study.
Mussini C; Pezzotti P; Govoni A; Borghi V; Antinori A; d'Arminio Monforte A; De Luca A; Mongiardo N; Cerri MC; Chiodo F; Concia E; Bonazzi L; Moroni M; Ortona L; Esposito R; Cossarizza A; De Rienzo B
J Infect Dis; 2000 May; 181(5):1635-42. PubMed ID: 10823763
[TBL] [Abstract][Full Text] [Related]
14. [Withdrawal of Pneumocystis carinii pneumonia prophylaxis in patients receiving efficacious combined antiretroviral treatment. Study of 85 cases].
García Vázquez E; de Górgolas Hernández M; García Delgado R; Fernández Guerrero ML
Med Clin (Barc); 1999 Jun; 113(3):89-90. PubMed ID: 10464742
[TBL] [Abstract][Full Text] [Related]
15. Prophylaxis against Pneumocystis carinii pneumonia in children infected with human immunodeficiency virus.
CDR (Lond Engl Wkly); 1991 Apr; 1(15):65. PubMed ID: 1669802
[No Abstract] [Full Text] [Related]
16. Editorial response: Prophylaxis for Pneumocystis carinii pneumonia--an evolving tale of two populations.
Gaut P; Daar ES
Clin Infect Dis; 1999 Oct; 29(4):784-6. PubMed ID: 10589888
[No Abstract] [Full Text] [Related]
17. [Possibilities of chemoprophylaxis and chemotherapy in protozoan opportunistic infections].
Ortona L; Antinori A
G Ital Chemioter; 1991; 38(1-3):83-5. PubMed ID: 1365619
[No Abstract] [Full Text] [Related]
18. New developments in the management of Pneumocystis carinii disease.
Safrin S
AIDS Clin Rev; 1993-1994; ():95-112. PubMed ID: 8217906
[No Abstract] [Full Text] [Related]
19. Treatment and prophylaxis of Pneumocystis carinii pneumonia.
Castro M
Semin Respir Infect; 1998 Dec; 13(4):296-303. PubMed ID: 9872626
[TBL] [Abstract][Full Text] [Related]
20. Prevention of Pneumocystis carinii pneumonia relapse in AIDS patients. The efficacy and tolerability of low-dose sulfamethoxazole-trimethoprim.
Nielsen TL; Jensen BN; Nelsing S; Pedersen C; Mathiesen LR; Skinhøj P; Nielsen JO
Dan Med Bull; 1993 Sep; 40(4):503-5. PubMed ID: 8222772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
